Dexamfetamine, a scheduled stimulant medication , is employed in Australia primarily for the management of hyperkinetic disorder and, less often , narcolepsy. Its access is strictly governed under the Therapeutic Goods Act , requiring a registered doctor's prescription. Individuals seeking dexamfetamine should be aware of its potential for addictio